OLN

OLN's cost cuts and planned Huntsman merger could boost earnings, while weak demand, leverage and cash flow remain key headwinds.

Huntsman NYSE: HUN stockholders approved the company's proposed merger agreement with Olin Corporation during a virtual special meeting held in 2026, clearing a key shareholder-vote requirement for the planned business combination.

Olin and Huntsman's shareholders overwhelmingly back their all-stock merger, advancing a $12.5 billion chemicals combination targeting more than $400 million in benefits.

Olin remains a valuable opportunity despite operational setbacks, sector headwinds, and a 12% share price decline over the past year. OLN's Q2 was impacted by a $40M Freeport outage, weak demand, and working capital drag, but its epoxy and ammunition businesses showed resilience. The pending Huntsman merger, expected by mid-2027, should drive $250M in cost synergies and improve OLN's free cash flow and leverage profile.

NEW YORK, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Olin Corporation (“Olin” or the “Company”) (NYSE: OLN).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

CLAYTON, Missouri and THE WOODLANDS, Texas, Aug. 25, 2026 /PRNewswire/ -- Olin Corporation (NYSE: OLN) and Huntsman Corporation (NYSE: HUN) today announced that their respective shareholders have approved the proposals necessary to complete the companies' previously announced all-stock merger of equals. "We greatly appreciate the strong support of Olin and Huntsman shareholders as we reach this important milestone," said Ken Lane, President and Chief Executive Officer of Olin.

NEW YORK, Aug. 20, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Olin Corporation ("Olin" or the "Company") (NYSE: OLN).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

NEW YORK, Aug. 13, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Olin Corporation ("Olin" or the "Company") (NYSE: OLN).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

Olin's Q2 revenues beat estimates as Epoxy and Winchester gains offset Chlor Alkali weakness, while adjusted EBITDA rises 8.6%.

NEW YORK, Aug. 6, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Olin Corporation ("Olin" or the "Company") (NYSE: OLN).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.